AI & Imaging
GEHC clearance adds PCCP route for contouring AI
MIM Contour ProtégéAI+ 2.0 adds MR brain and updated CT male pelvis models, with an FDA-cleared change plan for future model updates.
Section
All News
Every story we've published, newest first. 296 articles.
Business
Philips alliance spans WellSpan imaging network
The 7-year agreement names Philips as WellSpan’s preferred vendor across CT, MR, digital X-ray, ultrasound, and image-guided therapy.
Practice
ASTRO taps Virginia site for RPT training program
Virginia Cancer Specialists is one of the first 2 U.S. authorized user training centers for radiation oncologists seeking supervised radiopharmaceutical therapy experience.
Practice
ACR criteria update adds pediatric, sarcopenia topics
The latest ACR Appropriateness Criteria update adds 8 new topics and revises 8 existing ones across diagnostic imaging and interventional radiology guidance.
Business
QT acoustic breast CT gains Saudi market access
The Saudi Food and Drug Authority clearance allows QT Imaging’s Breast Acoustic CT scanner to be marketed, sold, and deployed through Gulf Medical.
Practice
Konica Minolta adds DR analytics dashboards
The AeroRemote Insights update adds productivity, clinical dose, and system health dashboards for digital radiography systems and wireless flat panel detectors.
Practice
Utah names Stanford AI leader radiology chair
David B. Larson, MD, MBA, will become chair of the University of Utah Department of Radiology and Imaging Sciences on September 14, 2026.
Clinical
7T MRI study links sleep patterns to glutamate levels
An Auburn University graduate student underwent 104 MRI scans over 18 months while wearing a sleep-tracking ring to study next-day brain chemistry.
Practice
MSK suit targets GEHC PET/CT motion software
The Delaware complaint alleges that GE HealthCare MotionFree-equipped PET/CT scanners infringe MSK patents covering image-based respiratory motion correction.
Business
RadNet eyes $200M debt raise for imaging expansion
The proposed incremental term loan would support acquisitions, organic expansion, health system partnerships, and general corporate purposes.